The design and analysis of Phase IIb Ebola vaccine trials
|
|
- Ophelia Charlotte Boone
- 5 years ago
- Views:
Transcription
1 The design and analysis of Phase IIb Ebola vaccine trials Ira Longini Department of Biostatistics Center for Statistical and Quantitative Infectious Diseases (CSQUID) Emerging Pathogens Institute University of Florida
2 Near-Term Development Plan: Pre-exposure use Nonclinical evaluat ion NHPs GMP grade vaccine Phase 1 trials Safety and dose selection Phase 2 trials Large scale safety Phase 2b trials Preliminary efficacy Phase 3 trials Phase 4 trials Dec st Quarter 2015 Peter talk about this Matthias talk about this Emergency use use under informed consent Data collection Mass vaccination Pending licensure Not affected areas Affected areas 2 Source: Ana Maria Haneo Restrepo, WHO
3 3
4 Vaccine Effectiveness * Intervention Population: 1 Overall VE overall = 1- (AR 1ave / AR 2u ) Control Population: 2 Vac f AR 1v Nonvac 1-f AR 1u Nonvac AR 2u Direct Indirect VE direct = 1- (AR 1v / AR 1u ) VE indirect = 1- (AR 1u / AR 2u ) Total VE total = 1- (AR 1v / AR 2u ) * Halloran, M.E., Longini, I.M. and Struchiner, C.J.: The Design and Analysis of Vaccine Studies. Springer (2009).
5 Source: Halloran and Longini. Science 12, (2014)
6 Measures of Vaccine Efficacy {VE(t) S, VE(t) P, VE(t) I } VE S Vaccine Effect on Susceptibility VE P Vaccine Effect on Clinical Disease Classical III vaccine trials Many times observe VE SP = 1 (1 VE S ) (1 VE P ) VE I Vaccine Effect on Infectiousness
7 Immune Correlates and Surrogates of Protection and Efficacy Can be estimated from RCT Possible antibody and CMI markers Compare immune markers in vaccinated infected and uninfected vaccinatedsubjects Surrogate is stronger than a correlate Main Prentice criterion p(inf S,V) = p(inf S) Inf infected, S surrogate marker, V- vaccinated
8 Vaccine efficacy definition VE = 1 RR = 1 - r v r u where r v is the rate in the vaccinated, and r u in the unvaccinated. Another view, where VE = 1 θ r v = θc v p and r u = c u p, c - contact rate, p - trans. Prob. VE = 1 - θc v p c u p = 1 - θ, when c v = c u, Per contact exposure must be the same in the vaccine and comparison groups to get unbiased estimate of the VE
9 Vaccine efficacy definition People in {v} and {u} must have equal levels of exposure (on average), i.e., statistically must be exchangeable Randomization accomplishes this! If no randomization Find comparable group Do a matched analysis Other tricks
10 Hierarchy of phase IIb and III vaccine trials 1. Double-blinded, randomized, placebo control trial (RCT) 2. Vaccine trials without placebo arm Step wedged design with randomized clusters or populations Opportunistic step wedged design 3. Vaccine trails without placebo arm or randomization Perspective with matched comparison arm Case control with matched controls Test negative case control design
11 Vaccination strategies The type of analysis depends on the strategies Who is vaccinated Health care workers and others with exposure to Ebola patients Others at high risk pre-exposure Contacts of cases Ring vaccination Vaccination of communities affected
12 Case ascertainment How are cases ascertained Active prospective observation or case finding Passive detection, e.g., people that show up a health facilities with early Ebola symptoms Most effective strategies will be targeted vaccination Pre vaccination Reactive vaccination
13 For prospective analysis of targeted groups Vaccinate groups of people Health care workers and front line workers Others at high risk pre-exposure Contacts of cases Ring vaccination Vaccination of communities affected
14 For prospective analysis of targeted groups Find set of controls matched by Age, gender Type and level of exposure Time Probably can not be in same location as vaccinated Can have small numbers vaccinated
15 Double-blinded, randomized, placebo control trial GSK (Rip) presentation yesterday was excellent Important features Powered to reject H 0 = 0 against some relatively low alternative. Sequential hypothesis testing frequently or even in continuous time such that if the null is rejected that the trial will be stopped and those in placebo arm with be immediately offered vaccine
16 Step wedged design
17 Vaccine trails without placebo arm or randomization
18 Simple prospective trial Pre-exposure vaccination of health workers or other high risk group Ascertainment at the health facility or high risk setting Comparisons Health works at another comparable health facility or high risk setting that does not have a vaccination program, further matching by level of exposure Prospective analysis
19 Test negative case control study for vaccine efficacy Case control design For each confirmed case select a matched control who has similar symptoms but tests negative for infection in question Do matched or unmatched analysis but using the subset of negative controls Must have relatively large number of people vaccinated
20 Retrospective and case-control designs Case Control (not case) Total vaccinated a b n v = a + b unvaccinated c d n u = c + d Total n c = a + c n nc = b + d n = a + b +c + d If the study were prospective, then VE = 1 - a/nv c/nu If the study were retrospective, then, VE 1 - a/c b/d 1 - ad/bc
21 De Serres, et al. Eurosurveillance, 18, Issue 37, 12 September 2013.
22 Statistics Variance, confidence intervals, hypothesis tests, power are all in approximate or exact closed forms Everything worked out for different methods for bias and confounding control Matching schemes Logistic regression can be used for more complex designs and multivariate analysis Cox proportional hazards model for rate ratios
23 The way forward Try to do RCT on a accelerated basis Stepped wedge could be done, randomized if possible Smaller, opportunistic prospective and case control designs could also be employed Test negative case control design could be used
24 Thank you
Analytic Methods for Infectious Disease Lecture 3
Analytic Methods for Infectious Disease Lecture 3 M. Elizabeth Halloran Hutchinson Research Center and University of Washington Seattle, WA, USA January 13, 2009 Herd Immunity Definition Manifestations
More informationModeling results / SDF: Routine vaccination strategy Introduction catch-up strategy
Modeling results / SDF: Routine vaccination strategy Introduction catch-up strategy Ira Longini, Diana Rojas, Tom Hladish CSQUID, University of Florida, Gainesville, FL Betz Halloran, Dennis Chao Fred
More informationAssessment of dengue vaccine effectiveness and impact for different rollout strategies
Assessment of dengue vaccine effectiveness and impact for different rollout strategies Diana P. Rojas and Ira Longini Center for Inference and Dynamics of Infectious Diseases Emerging Pathogens Institute
More informationMathematical Models for the Control of Infectious Diseases With Vaccines
Mathematical Models for the Control of Infectious Diseases With Vaccines Ira Longini Department of Biostatistics and Center for Statistical and Quantitative Infectious Diseases (CSQUID), University of
More informationLecture 9: Study designs for evaluating vaccine efficacy N ATA L IE DEA N A N D IRA LON GIN I
Lecture 9: Study designs for evaluating vaccine efficacy N ATA L IE DEA N A N D IRA LON GIN I DEPARTMENT OF BIOSTATISTICS UN IV ERSITY OF FLORIDA Goal of vaccine studies Evaluate vaccine efficacy and effectiveness
More informationStatistical Science Issues in HIV Vaccine Trials: Part I
Statistical Science Issues in HIV Vaccine Trials: Part I 1 2 Outline 1. Study population 2. Criteria for selecting a vaccine for efficacy testing 3. Measuring effects of vaccination - biological markers
More informationEbola Prevention Vaccine Evaluation in Sierra Leone
Ebola Prevention Vaccine Evaluation in Sierra Leone Dr. SAS Kargbo Sierra Leone Ministry of Health and Sanitation Sierra Leone CDC Collaboration World Health Organization, Geneva 9 January 2015 Principal
More informationAUGMENTED HIV VACCINE TRIAL DESIGN FOR ESTIMATING REDUCTION IN INFECTIOUSNESS AND PROTECTIVE EFFICACY
STATISTICS IN MEDICINE, VOL. 17, 185 200 (1998) AUGMENTED HIV VACCINE TRIAL DESIGN FOR ESTIMATING REDUCTION IN INFECTIOUSNESS AND PROTECTIVE EFFICAC SUSMITA DATTA, M. ELIZABETH HALLORAN* AND IRA M. LONGINI,
More informationConcepts of herd protection and immunity
Available online at www.sciencedirect.com Procedia in Vaccinology 2 (2010) 134 139 Ninth Global Vaccine Research Forum and Parallel Satellite Symposia, Bamako, Mali, 6-9 December 2009 Concepts of herd
More informationModeling the effectiveness of mass cholera vaccination in Bangladesh
Modeling the effectiveness of mass cholera vaccination in Bangladesh Dennis Chao April 20, 2016 1 / 20 Vibrio cholerae in Bangladesh Ali et al. Updated Global Burden of Cholera in Endemic Countries. PLoS
More informationOverview of Vaccine Effects and Study Designs
2 Overview of Vaccine Effects and Study Designs 2.1 Introduction In this chapter, we present a systematic framework about the relation among many of the different types of vaccination effects and the parameters
More informationHerd Protection- Efficacy vs effectiveness The Importance of Cluster-Randomized Trials to assess Vaccine Herd Protection
Herd Protection- Efficacy vs effectiveness The Importance of Cluster-Randomized Trials to assess Vaccine Herd Protection Anna Lena Lopez, MD, MPH University of the Philippines Manila- National Institutes
More informationHerd Protective Effects of Vaccines. John Clemens icddr,b, Dhaka, Bangladesh
Herd Protective Effects of Vaccines John Clemens icddr,b, Dhaka, Bangladesh Promising Vaccine Candidate Phase I. Safe and Immunogenic in Healthy Adults? Yes No Phase II. Safe and Immunogenic in the Target
More informationInfluenza vaccine effectiveness assessment in the UK. Nick Andrews, Statistics Unit, Health Protection Agency
Influenza vaccine effectiveness assessment in the UK Nick Andrews, Statistics Unit, Health Protection Agency 1 Outline Introduction The UK swabbing schemes Assessment by the test negative case control
More informationGSK Proposed Phase 2 Program for ChAd3 EBOV Vaccine Candidate
GSK Proposed Phase 2 Program for ChAd3 EBOV Vaccine Candidate Vaccine availability for Phase 2 program Dependent upon: Dose level selected in Phase 1 Productivity of the current manufacturing process (at
More informationHow to launch a parallel or sequential pathways for experimental evaluation of Ebola candidate vaccines in Phase 3 Ebola vaccine clinical trials?
Accelerating access to Ebola vaccines How to launch a parallel or sequential pathways for experimental evaluation of Ebola candidate vaccines in Phase 3 Ebola vaccine clinical trials? Dr Ana Maria Henao-Restrepo
More informationBIOST/STAT 578 A Statistical Methods in Infectious Diseases Lecture 16 February 26, Cholera: ecological determinants and vaccination
BIOST/STAT 578 A Statistical Methods in Infectious Diseases Lecture 16 February 26, 2009 Cholera: ecological determinants and vaccination Latest big epidemic in Zimbabwe Support International Vaccine
More informationHarvard University. Leveraging Contact Network Structure in the Design of Cluster Randomized Trials
Harvard University Harvard University Biostatistics Working Paper Series Year 2016 Paper 199 Leveraging Contact Network Structure in the Design of Cluster Randomized Trials Guy Harling Rui Wang Jukka-Pekka
More informationThe Effects of Herd Immunity on the Power of Vaccine Trials
University of California, Los Angeles From the SelectedWorks of Ron Brookmeyer 2009 The Effects of Herd Immunity on the Power of Vaccine Trials Blake Charvat Ron Brookmeyer, Johns Hopkins Bloomberg School
More informationLecture 5 Conducting Interviews and Focus Groups
Lecture 5 Conducting Interviews and Focus Groups Talking to participants enables in-depth information about the experiences of health and illness; and of factors that influence health and illness behaviour
More informationFundamental Clinical Trial Design
Design, Monitoring, and Analysis of Clinical Trials Session 1 Overview and Introduction Overview Scott S. Emerson, M.D., Ph.D. Professor of Biostatistics, University of Washington February 17-19, 2003
More informationCritical Appraisal Series
Definition for therapeutic study Terms Definitions Study design section Observational descriptive studies Observational analytical studies Experimental studies Pragmatic trial Cluster trial Researcher
More informationModule 5: Introduction to Stochastic Epidemic Models with Inference
Module 5: Introduction to Stochastic Epidemic Models with Inference Instructors: Tom Britton, Dept. Mathematics, Stockholm University Ira Longini, Dept. Biostatistics, University of Florida Jonathan Sugimoto,
More informationCHL 5225 H Advanced Statistical Methods for Clinical Trials. CHL 5225 H The Language of Clinical Trials
CHL 5225 H Advanced Statistical Methods for Clinical Trials Two sources for course material 1. Electronic blackboard required readings 2. www.andywillan.com/chl5225h code of conduct course outline schedule
More informationRapid appraisal of the literature: Identifying study biases
Rapid appraisal of the literature: Identifying study biases Rita Popat, PhD Clinical Assistant Professor Division of Epidemiology Stanford University School of Medicine August 7, 2007 What is critical
More informationConcepts of herd immunity and protection
Fondation Mérieux Conference Herd Immunity/Protection: an Important Indirect Benefit of Vaccination - Annecy- 26 th October 2010 Concepts of herd immunity and protection Peter Smith London School of Hygiene
More informationVaccine Efficacy, Effectiveness and Impact. G. HANQUET, KCE, 9 September 2017
Vaccine Efficacy, Effectiveness and Impact G. HANQUET, KCE, 9 September 2017 RvB - CA, 16/09/2014 Outline The confusion Vaccine effects Methodologies Challenges Implications for decision making 2 Life
More informationModule 5: Introduction to Stochastic Epidemic Models with Inference
Module 5: Introduction to Stochastic Epidemic Models with Inference Instructors:, Dept. Mathematics, Stockholm University Ira Longini, Dept. Biostatistics, University of Florida Jonathan Sugimoto, Vaccine
More informationObjectives. Distinguish between primary and secondary studies. Discuss ways to assess methodological quality. Review limitations of all studies.
Study Design Objectives 2 Distinguish between primary and secondary studies. Discuss ways to assess methodological quality. Review limitations of all studies. Key Terms 3 Evidence based medicine Primary
More informationEffectiveness of rotavirus vaccination Generic study protocol for retrospective case control studies based on computerised databases
TECHNICAL DOCUMENT Effectiveness of rotavirus vaccination Generic study protocol for retrospective case control studies based on computerised databases www.ecdc.europa.eu ECDC TECHNICAL DOCUMENT Effectiveness
More informationEvaluating Protective Effects of Vaccination
6 Evaluating Protective Effects of Vaccination 6.1 Overview In this and the next few chapters, we consider evaluating direct protective effects of vaccination in studies that do not condition on exposure
More informationApplied Analysis of Variance and Experimental Design. Lukas Meier, Seminar für Statistik
Applied Analysis of Variance and Experimental Design Lukas Meier, Seminar für Statistik About Me Studied mathematics at ETH. Worked at the statistical consulting service and did a PhD in statistics (at
More informationStatistical considerations in indirect comparisons and network meta-analysis
Statistical considerations in indirect comparisons and network meta-analysis Said Business School, Oxford, UK March 18-19, 2013 Cochrane Comparing Multiple Interventions Methods Group Oxford Training event,
More informationTypes of Biomedical Research
INTRODUCTION & MEASUREMENT IN CLINICAL RESEARCH Sakda Arj Ong Vallipakorn, MD MSIT, MA (Information Science) Pediatrics, Pediatric Cardiology Emergency Medicine, Ped Emergency Family Medicine Section of
More information12/26/2013. Types of Biomedical Research. Clinical Research. 7Steps to do research INTRODUCTION & MEASUREMENT IN CLINICAL RESEARCH S T A T I S T I C
Types of Biomedical Research INTRODUCTION & MEASUREMENT IN CLINICAL RESEARCH Sakda Arj Ong Vallipakorn, MD MSIT, MA (Information Science) Pediatrics, Pediatric Cardiology Emergency Medicine, Ped Emergency
More informationStudy design. Chapter 64. Research Methodology S.B. MARTINS, A. ZIN, W. ZIN
Chapter 64 Study design S.B. MARTINS, A. ZIN, W. ZIN Research Methodology Scientific methodology comprises a set of rules and procedures to investigate the phenomena of interest. These rules and procedures
More informationCommon Statistical Issues in Biomedical Research
Common Statistical Issues in Biomedical Research Howard Cabral, Ph.D., M.P.H. Boston University CTSI Boston University School of Public Health Department of Biostatistics May 15, 2013 1 Overview of Basic
More informationMathematical modeling of cholera
Mathematical modeling of cholera Dennis Chao Center for Statistics and Quantitative Infectious Diseases (CSQUID) Vaccine and Infectious Disease Division Fred Hutchinson Cancer Research Center 22 April,
More informationEpidemiology & Evidence Based Medicine. Patrick Linden & Matthew McCall
Epidemiology & Evidence Based Medicine Patrick Linden & Matthew McCall Areas Covered in this Talk Bradford Hill Criteria Bias and confounding Study designs, advantages and disadvantages Basic definitions
More informationAssessing public health impact through vaccine probe analyses. Robert F. Breiman Emory Global Health Institute Emory University
Assessing public health impact through vaccine probe analyses Robert F. Breiman Emory Global Health Institute Emory University State of understanding the relative role of pathogens in major disease syndromes
More informationVaccine Trial Designs. Dean Follmann NIH
Vaccine Trial Designs Dean Follmann NIH Outline: Vaccines Trial Designs Randomized Vaccine Designs for Licensure Phase I - Phase III Animal Rule for Licensure Inhalational Anthrax Observational Vaccine
More informationAbstract Title Page Not included in page count. Title: Analyzing Empirical Evaluations of Non-experimental Methods in Field Settings
Abstract Title Page Not included in page count. Title: Analyzing Empirical Evaluations of Non-experimental Methods in Field Settings Authors and Affiliations: Peter M. Steiner, University of Wisconsin-Madison
More informationTrial Designs. Professor Peter Cameron
Trial Designs Professor Peter Cameron OVERVIEW Review of Observational methods Principles of experimental design applied to observational studies Population Selection Looking for bias Inference Analysis
More informationComplier Average Causal Effect (CACE)
Complier Average Causal Effect (CACE) Booil Jo Stanford University Methodological Advancement Meeting Innovative Directions in Estimating Impact Office of Planning, Research & Evaluation Administration
More informationChapter 13 Summary Experiments and Observational Studies
Chapter 13 Summary Experiments and Observational Studies What have we learned? We can recognize sample surveys, observational studies, and randomized comparative experiments. o These methods collect data
More informationChapter 13. Experiments and Observational Studies. Copyright 2012, 2008, 2005 Pearson Education, Inc.
Chapter 13 Experiments and Observational Studies Copyright 2012, 2008, 2005 Pearson Education, Inc. Observational Studies In an observational study, researchers don t assign choices; they simply observe
More informationOverview of Study Designs
Overview of Study Designs Kyoungmi Kim, Ph.D. July 13 & 20, 2016 This seminar is jointly supported by the following NIH-funded centers: We are video recording this seminar so please hold questions until
More informationIs my vaccination programme working? Vaccine effectiveness: measuring vaccine protection in the field
Is my vaccination programme working? Vaccine effectiveness: measuring vaccine protection in the field Theo Knight-Jones FAO-EU-EuFMD webinar for West-Eurasian veterinary services 15 January 2015 Contents
More informationPower to Detect the Effects of HIV Vaccination in Repeated Low-Dose Challenge Experiments
BRIEF REPORT Power to Detect the Effects of HIV Vaccination in Repeated Low-Dose Challenge Experiments Michael G. Hudgens, 1 Peter B. Gilbert, 2 John R. Mascola, 3 Chih-Da Wu, 1 Dan H. Barouch, 4 and Steven
More informationThe comparison or control group may be allocated a placebo intervention, an alternative real intervention or no intervention at all.
1. RANDOMISED CONTROLLED TRIALS (Treatment studies) (Relevant JAMA User s Guides, Numbers IIA & B: references (3,4) Introduction: The most valid study design for assessing the effectiveness (both the benefits
More informationPotential public health impact of RSV vaccines. R. Karron December 2016
Potential public health impact of RSV vaccines R. Karron December 2016 1. RSV is The leading cause of hospitalization in infants and in many high-income countries; >2 million medical visits annually in
More informationChallenges of Observational and Retrospective Studies
Challenges of Observational and Retrospective Studies Kyoungmi Kim, Ph.D. March 8, 2017 This seminar is jointly supported by the following NIH-funded centers: Background There are several methods in which
More informationThe Roles of Short Term Endpoints in. Clinical Trial Planning and Design
The Roles of Short Term Endpoints in Clinical Trial Planning and Design Christopher Jennison Department of Mathematical Sciences, University of Bath, UK http://people.bath.ac.uk/mascj Roche, Welwyn Garden
More informationClinical problems and choice of study designs
Evidence Based Dentistry Clinical problems and choice of study designs Asbjørn Jokstad University of Oslo, Norway Nov 21 2001 1 Manipulation with intervention Yes Experimental study No Non-experimental
More informationSession 9. Correlate of Protection (CoP) (Plotkin and Gilbert, CID 2012)
Module 8 Evaluating Immunological Correlates of Protection Session 9 Validation Using Prentice Criteria and Causal Inference Framework, Design Considerations Ivan S.F. Chan, Ph.D. Merck Research Laboratories
More informationEvidence Based Medicine
Course Goals Goals 1. Understand basic concepts of evidence based medicine (EBM) and how EBM facilitates optimal patient care. 2. Develop a basic understanding of how clinical research studies are designed
More informationReflection Questions for Math 58B
Reflection Questions for Math 58B Johanna Hardin Spring 2017 Chapter 1, Section 1 binomial probabilities 1. What is a p-value? 2. What is the difference between a one- and two-sided hypothesis? 3. What
More informationVocabulary. Bias. Blinding. Block. Cluster sample
Bias Blinding Block Census Cluster sample Confounding Control group Convenience sample Designs Experiment Experimental units Factor Level Any systematic failure of a sampling method to represent its population
More informationEvidence-Based Medicine Journal Club. A Primer in Statistics, Study Design, and Epidemiology. August, 2013
Evidence-Based Medicine Journal Club A Primer in Statistics, Study Design, and Epidemiology August, 2013 Rationale for EBM Conscientious, explicit, and judicious use Beyond clinical experience and physiologic
More informationOverview of Study Designs in Clinical Research
Overview of Study Designs in Clinical Research Systematic Reviews (SR), Meta-Analysis Best Evidence / Evidence Guidelines + Evidence Summaries Randomized, controlled trials (RCT) Clinical trials, Cohort
More informationLearning Objectives 9/9/2013. Hypothesis Testing. Conflicts of Interest. Descriptive statistics: Numerical methods Measures of Central Tendency
Conflicts of Interest I have no conflict of interest to disclose Biostatistics Kevin M. Sowinski, Pharm.D., FCCP Last-Chance Ambulatory Care Webinar Thursday, September 5, 2013 Learning Objectives For
More informationSchool of Population and Public Health SPPH 503 Epidemiologic methods II January to April 2019
School of Population and Public Health SPPH 503 Epidemiologic methods II January to April 2019 Time: Tuesday, 1330 1630 Location: School of Population and Public Health, UBC Course description Students
More information9/4/2013. Decision Errors. Hypothesis Testing. Conflicts of Interest. Descriptive statistics: Numerical methods Measures of Central Tendency
Conflicts of Interest I have no conflict of interest to disclose Biostatistics Kevin M. Sowinski, Pharm.D., FCCP Pharmacotherapy Webinar Review Course Tuesday, September 3, 2013 Descriptive statistics:
More informationEstimation of Vaccine Efficacy in the Presence of Waning: Application to Cholera Vaccines
American Journal of Epidemiology Copyright O 1998 by The Johns Hopkins University School of Hygiene and PubBc Hearth All rights reserved Vol. 147, No. 1 Printed In USA Estimation of Vaccine Efficacy in
More informationIncorporating Infecting Pathogen Counts In Vaccine Trials. Dean Follmann National Institute of Allergy and Infectious Diseases
Incorporating Infecting Pathogen Counts In Vaccine Trials Dean Follmann National Institute of Allergy and Infectious Diseases Vaccine Trial Randomize at risk healthy volunteers to vaccine or placebo Follow
More informationEfficacy Results from the Step Study
Efficacy Results from the Step Study (Merck V520 Protocol 023/HVTN 502) A Phase II Test-of-Concept Trial of the MRKAd5 HIV-1 Gag/Pol/Nef Trivalent Vaccine CROI February 5, 2008 Boston, MA Rationale for
More informationDetermining the size of a vaccine trial
17th Advanced Vaccinology Course Annecy 26 th May 2016 Determining the size of a vaccine trial Peter Smith London School of Hygiene & Tropical Medicine Purposes of lecture Introduce concepts of statistical
More informationConfounding. Confounding and effect modification. Example (after Rothman, 1998) Beer and Rectal Ca. Confounding (after Rothman, 1998)
Confounding Confounding and effect modification Epidemiology 511 W. A. Kukull vember 23 2004 A function of the complex interrelationships between various exposures and disease. Occurs when the disease
More informationEBM, Study Design and Numbers. David Frankfurter, MD Professor OB/GYN The George Washington University
EBM, Study Design and Numbers David Frankfurter, MD Professor OB/GYN The George Washington University 1978? 1978 Best Picture of 1978 The Deer Hunter Universal Studios The 50th Academy Awards were held
More informationPrimary Research Question and Definition of Endpoints. Mario Chen The Fundamentals of Biostatistics in Clinical Research Workshop India, March 2007
Primary Research Question and Definition of Endpoints Mario Chen The Fundamentals of Biostatistics in Clinical Research Workshop India, March 2007 Research Questions Uncertainty that the investigator wants
More informationOverview. Goals of Interpretation. Methodology. Reasons to Read and Evaluate
Overview Critical Literature Evaluation and Biostatistics Ahl Ashley N. Lewis, PharmD, BCPS Clinical Specialist, Drug Information UNC Hospitals Background Review of basic statistics Statistical tests Clinical
More informationINTERNAL VALIDITY, BIAS AND CONFOUNDING
OCW Epidemiology and Biostatistics, 2010 J. Forrester, PhD Tufts University School of Medicine October 6, 2010 INTERNAL VALIDITY, BIAS AND CONFOUNDING Learning objectives for this session: 1) Understand
More informationHow should they be evaluated and what evidence is needed for WHO endorsement?
New predictive tests for the diagnosis of tuberculosis infection How should they be evaluated and what evidence is needed for WHO endorsement? Frank Cobelens KNCV Tuberculosis Foundation The Hague, Netherlands
More informationMathematical modelling of infectious disease transmission
Mathematical modelling of infectious disease transmission Dennis Chao Vaccine and Infectious Disease Division Fred Hutchinson Cancer Research Center 11 May 2015 1 / 41 Role of models in epidemiology Mathematical
More informationIncorporating Clinical Information into the Label
ECC Population Health Group LLC expertise-driven consulting in global maternal-child health & pharmacoepidemiology Incorporating Clinical Information into the Label Labels without Categories: A Workshop
More informationUse of blinded independent central review of PFS in definitive trials
Use of blinded independent central review of PFS in definitive trials Lori E. Dodd, PhD Biostatistics Research Branch National Institute of Allergy and Infectious Diseases 1 Progression-free survival Use
More informationConfounding in influenza VE studies in seniors, and possible solutions
Confounding in influenza VE studies in seniors, and possible solutions Michael L. Jackson Group Health Research Institute 4 th December, 2012 1 Outline Focus is on non-specific outcomes (e.g. community-acquired
More informationLecture 9: Stochastic models for arboviruses. Ira Longini
Lecture 9: Stochastic models for arboviruses Ira Longini The Ross-MacDonald Model for Vector Bourne Infectious Diseases Sir Ronald Ross (1857-1932) Liverpool School of Tropical Medicine The 2 nd Nobel
More informationA Framework for Assessing Immunological Correlates of Protection in Vaccine Trials
MAJOR ARTICLE A Framework for Assessing Immunological Correlates of Protection in Vaccine Trials Li Qin, 1,3 Peter B. Gilbert, 1,3 Lawrence Corey, 2,4,5,6 M. Juliana McElrath, 2,4,5 and Steven G. Self
More informationDependency of Vaccine Efficacy on Pre-Exposure and Age: A Closer Look at a Tetravalent Dengue Vaccine
Dependency of Vaccine Efficacy on Pre-Exposure and Age: A Closer Look at a Tetravalent Dengue Vaccine Yang Yang, PhD 1, Ya Meng, PhD 1, M. Elizabeth Halloran, DSc, MD 2,3, Ira M. Longini, Jr., PhD 1 August
More informationCalifornia 2010 Pertussis Epidemic. Kathleen Winter, MPH Immunization Branch California Department of Public Health
California 2010 Pertussis Epidemic Kathleen Winter, MPH Immunization Branch California Department of Public Health Overview Pertussis Background California Pertussis Epidemic Challenges and Success Ongoing
More informationPhD Course in Biostatistics
PhD Course in Biostatistics Univ.-Prof. DI Dr. Andrea Berghold Institute for Medical Informatics, Statistics and Documentation Medical University of Graz andrea.berghold@medunigraz.at Content Introduction
More informationPurpose. Study Designs. Objectives. Observational Studies. Analytic Studies
Purpose Study Designs H.S. Teitelbaum, DO, PhD, MPH, FAOCOPM AOCOPM Annual Meeting Introduce notions of study design Clarify common terminology used with description and interpretation of information collected
More informationVaccination schedules in Denmark
Vaccination schedules in Denmark Tyra Grove Krause MD, PhD, Senior consultant Head of Dept. Of Infectious Disease Epidemiology and Prevention Statens Serum Institut e-mail: tgv@ssi.dk Agenda History of
More informationProtocol Development: The Guiding Light of Any Clinical Study
Protocol Development: The Guiding Light of Any Clinical Study Susan G. Fisher, Ph.D. Chair, Department of Clinical Sciences 1 Introduction Importance/ relevance/ gaps in knowledge Specific purpose of the
More informationUnit 1 Exploring and Understanding Data
Unit 1 Exploring and Understanding Data Area Principle Bar Chart Boxplot Conditional Distribution Dotplot Empirical Rule Five Number Summary Frequency Distribution Frequency Polygon Histogram Interquartile
More informationProf. Armando Torres Nephrology Section Hospital Universitario de Canarias University of La Laguna Tenerife, Canary Islands, Spain.
Does RAS blockade improve outcomes after kidney transplantation? Armando Torres, La Laguna, Spain Chairs: Hans De Fijter, Leiden, The Netherlands Armando Torres, La Laguna, Spain Prof. Armando Torres Nephrology
More informationDesign of Experiments & Introduction to Research
Design of Experiments & Introduction to Research 1 Design of Experiments Introduction to Research Definition and Purpose Scientific Method Research Project Paradigm Structure of a Research Project Types
More informationChapter 2. Epidemiological and Toxicological Studies
Chapter 2 Epidemiological and Toxicological Studies Introduction Epidemiological and toxicological studies seek to determine the cause of a particular illness or disease. Etiology is the study of causes.
More informationFMD VACCINES AND THEIR USE IN VACCINATION PROGRAMMES: THEORY AND PRACTICE
FMD VACCINES AND THEIR USE IN VACCINATION PROGRAMMES: THEORY AND PRACTICE Chris Bartels, Melissa McLaws, Naser Rasouli, Theodore Knight-Jones, Keith Sumption Endemic FMD region Context EUFMD project activities
More informationDESIGN OF VACCINE EFFICACY TRIALS TO BE USED DURING PUBLIC HEALTH EMERGENCIES POINTS OF CONSIDERATIONS AND KEY PRINCIPLES
DESIGN OF VACCINE EFFICACY TRIALS TO BE USED DURING PUBLIC HEALTH EMERGENCIES POINTS OF CONSIDERATIONS AND KEY PRINCIPLES 1 CONTENTS Contents... 2 1 Acknowledgments... 4 2 Abbreviations and Acronyms...
More informationResearch Methodology Workshop. Study Type
Research Methodology Workshop Study Type What type of question? Frequency: how common is it? Aetiology: What caused this? Intervention: Does this intervention work? Diagnosis or test evaluation: How accurate
More informationCritical Appraisal of RCT
Critical Appraisal of RCT What is critical appraisal? Definition Process of systematically examining research evidence to assess its reliability (validity/internal validity), results and relevance (external
More informationCohort studies. Training course in research methodology and research protocol development Geneva Nguyen Thi My Huong, MD PhD WHO/RHR/SIS
Cohort studies Training course in research methodology and research protocol development Geneva 2018 Nguyen Thi My Huong, MD PhD WHO/RHR/SIS OUTLINE Overview Definitions Study design Basic measures Advantages
More informationObservational Study Designs. Review. Today. Measures of disease occurrence. Cohort Studies
Observational Study Designs Denise Boudreau, PhD Center for Health Studies Group Health Cooperative Today Review cohort studies Case-control studies Design Identifying cases and controls Measuring exposure
More informationAuthor's response to reviews
Author's response to reviews Title: Pneumococcal vaccination and otitis media in Australian Aboriginal infants: comparison of two birth cohorts before and after introduction of vaccination Authors: Grant
More informationCOMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP) NOTE FOR GUIDANCE ON CLINICAL EVALUATION OF NEW VACCINES
The European Agency for the Evaluation of Medicinal Products Human Medicines Evaluation Unit London, 19 May 1999 COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP) NOTE FOR GUIDANCE ON CLINICAL EVALUATION
More informationA Measles Epidemic in a Highly Vaccinated Population ( Measles in Burundi )
Centers for Disease Control and Prevention Epidemiology Program Office Case Studies in Applied Epidemiology No. 911-102 A Measles Epidemic in a Highly Vaccinated Population ( Measles in Burundi ) Learning
More informationAnatomy of Medical Studies: Part I. Emily D Agostino Epidemiology and Biostatistics CUNY School of Public Health at Hunter College
Anatomy of Medical Studies: Part I!! Emily D Agostino Epidemiology and Biostatistics CUNY School of Public Health at Hunter College I. Standard format of a Medical Study Abstract (quick overview: what
More informationFIRST DO NO HARM: AN EBM ODYSSEY. Cathleen Colón-Emeric, MD, MHS Geriatrics, Department of Medicine Durham VA GRECC
FIRST DO NO HARM: AN EBM ODYSSEY Cathleen Colón-Emeric, MD, MHS Geriatrics, Department of Medicine Durham VA GRECC colon001@mc.duke.edu 919 660-7517 Learning Objectives 1. Describe the types of studies
More information